NEW YORK, Dec. 29, 2008 –-The New York Stock Exchange announced that trading in the Class A Common Stock of Alpharma Inc. [NYSE: ALO] will be halted prior to the opening of the market on Monday, December 29, 2008, pending the expiration of the offer to purchase the Class A Common Stock of Alpharma by Albert Acquisition Corp., a wholly-owned subsidiary of King Pharmaceuticals, Inc. [NYSE: KG]. The offer is set to expire on December 29, 2008 at 10:00 a.m. New York City time.
New York Stock Exchange to Halt Trading of the Class A Common Stock of Alpharma Inc.
The halt will be in effect until the results of the offer are made available, unless the offer is extended.
Reporters requiring more information about this NYSE trading halt can contact the NYSE news line, 212-656-2065.